1. Repository of OAI
Ελληνικά   English  

Browsing by Author Filippatos, T. D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 37 to 56 of 59 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemiaAgouridis, A. P.; Tsimihodimos, V.; Filippatos, T. D.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Tsimihodimos, V.; Kostapanos, M. S.; Doumas, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Hypertriglyceridaemic waist phenotype definitions and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Kostapanos, M. S.; Saougos, V. G.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterolGazi, I. F.; Filippatos, T. D.; Tsimihodimos, V.; Saougos, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndromeFilippatos, T. D.; Derdemezis, C. S.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased plasma visfatin concentration is a marker of an atherogenic metabolic profileFilippatos, T. D.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased plasma visfatin levels in subjects with the metabolic syndromeFilippatos, T. D.; Derdemezis, C. S.; Gazi, I. F.; Lagos, K.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
LDL cholesterol estimation in patients with the metabolic syndromeGazi, I.; Tsimihodimos, V.; Filippatos, T. D.; Saougos, V. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatmentDerdemezis, C. S.; Filippatos, T. D.; Voulgari, P. V.; Tselepis, A. D.; Drosos, A. A.; Kiortsis, D. N.24-Nov-2015-
Leptospirosis is Associated with Markedly Increased Triglycerides and Small Dense Low-Density Lipoprotein and Decreased High-Density LipoproteinGazi, I. F.; Apostolou, F.; Liberopoulos, E. N.; Filippatos, T. D.; Tellis, C. C.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Orlistat-associated adverse effects and drug interactions: a critical reviewFilippatos, T. D.; Derdemezis, C. S.; Gazi, I. F.; Nakou, E. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Phenotype determinants of the thiglycerides lowering effect of rosuvastatinKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Saougos, V. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Plasma PAF-acetylhydrolase(Lp-PLA(2)) activity as a marker of small-dense LDL in subjects at median cardiovascular riskFilippatos, T. D.; Gazi, I.; Kiortsis, D. N.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015-
Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol loweringDerdemezis, C. S.; Filippatos, T. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
A review of the metabolic effects of sibutramineFilippatos, T. D.; Kiortsis, D. N.; Liberopoulos, E. N.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular diseaseKei, A. A.; Filippatos, T. D.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Role of ezetimibe in non-alcoholic fatty liver diseaseFilippatos, T. D.; Elisaf, M. S.24-Nov-2015-
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individualsMilionis, H. J.; Filippatos, T. D.; Loukas, T.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Small dense LDL cholesterol and apolipoproteins C-II and C-III in non-diabetic obese subjects with metabolic syndromeFilippatos, T. D.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Balraktari, E. T.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?Milionis, H. J.; Gazi, I. F.; Filippatos, T. D.; Tzovaras, V.; Chasiotis, G.; Goudevenos, J.; Seferiadis, K.; Elisaf, M. S.24-Nov-2015-
Showing results 37 to 56 of 59 < previous   next >